Targeting the Surface of the Protein 14-3-3 by Ultrasmall (1.5 nm) Gold Nanoparticles Carrying the Specific Peptide CRaf.
Tatjana RuksKateryna LozaMarc HeggenChristian OttmannPeter BayerChristine BeuckMatthias EpplePublished in: Chembiochem : a European journal of chemical biology (2021)
The surface of ultrasmall gold nanoparticles with an average diameter of 1.55 nm was conjugated with a 14-3-3 protein-binding peptide derived from CRaf. Each particle carries 18 CRaf peptides, leading to an overall stoichiometry of Au(115)Craf(18). The binding to the protein 14-3-3 was probed by isothermal titration calorimetry (ITC) and fluorescence polarization spectroscopy (FP). The dissociation constant (KD ) was measured as 5.0 μM by ITC and 0.9 μM by FP, which was close to the affinity of dissolved CRaf to 14-3-3σ. In contrast to dissolved CRaf, which alone did not enter HeLa cells, CRAF-conjugated gold nanoparticles were well taken up by HeLa cells, opening the opportunity to target the protein inside a cell.
Keyphrases
- gold nanoparticles
- cell cycle arrest
- induced apoptosis
- photodynamic therapy
- amino acid
- reduced graphene oxide
- protein protein
- binding protein
- single molecule
- magnetic resonance
- cell death
- high resolution
- magnetic resonance imaging
- oxidative stress
- single cell
- sensitive detection
- cancer therapy
- dna binding
- pi k akt
- cell therapy
- signaling pathway
- iron oxide
- drug delivery
- optic nerve
- capillary electrophoresis
- light emitting